# SANAD Health — Government Proposal

**A Proposal to the Ministry of Health, Kingdom of Saudi Arabia**

**Sovereign Health Intelligence Platform for National Deployment**

*Submitted by Sanad Technologies*

---

## 1. Strategic Rationale and Vision 2030 Alignment

### 1.1 The Imperative

The Kingdom's healthcare transformation under Vision 2030 calls for a system that is digitally connected, quality-driven, and citizen-centric. As AI becomes integral to clinical workflows, a foundational question arises: how will the Kingdom govern the intelligence that informs its health decisions?

Today, clinical data is fragmented across institutions. AI-generated decisions lack traceability. Consent mechanisms are procedural rather than structural. And reliance on foreign health-AI platforms creates sovereignty exposure that is inconsistent with national interests and PDPL obligations.

### 1.2 Vision 2030 Alignment

SANAD Health aligns directly with the following Vision 2030 strategic objectives:

- **Health Sector Transformation Program:** Providing the digital infrastructure for interoperable, quality-driven healthcare across public and private sectors.
- **National Data Management Office objectives:** Establishing sovereign, PDPL-compliant data governance for the health sector.
- **Localization and capacity building:** Building nationally controlled health-AI capabilities that reduce dependence on foreign platforms.
- **Citizen empowerment:** Operationalizing data-subject rights in a way citizens can see, use, and trust.

### 1.3 What SANAD Health Is

SANAD Health is a national AI health-intelligence platform developed by Sanad Technologies. It operates under the category of **Sovereign Health Intelligence** (الذكاء الصحي السيادي) and is built on a single principle: every health decision — human or AI-generated — must be traceable, explainable, and sovereign.

The platform currently comprises twelve role-based portals (Physician, Citizen, Emergency, Ministry, AI Control, Laboratory, Pharmacy, Hospital, Insurance, Research, Family, Supply Chain), a deterministic clinical decision engine, a severity-graded drug-interaction engine, a twelve-month digital-twin projection engine, consent enforcement at the data boundary, insurance fraud detection, and a tamper-evident cryptographic audit chain (Isnād).

---

## 2. Sovereignty and PDPL Compliance Posture

### 2.1 Data Sovereignty Architecture

SANAD is architected for deployment under full national control:

- **Data residency:** All patient data, AI decisions, and audit logs reside within the Kingdom's infrastructure. No data is processed by or transmitted to external parties.
- **Algorithmic transparency:** Every AI decision produces a structured explanation — contributing factors, weights, and confidence levels — that is recorded in the Isnād audit chain and available for regulatory review.
- **No foreign dependencies for core intelligence:** The clinical decision engine, drug-interaction engine, and fraud-detection engine are built and operated by Sanad Technologies. They do not rely on external AI APIs or foreign-hosted model inference.

### 2.2 PDPL Compliance

SANAD's architecture is designed to operationalize the requirements of نظام حماية البيانات الشخصية:

| PDPL Principle | SANAD Implementation |
|---|---|
| **Lawful basis for processing** | Each consent type in SANAD carries its legal basis (MOH directives, PDPL articles). Processing occurs only under documented authority. |
| **Data-subject rights** | Citizens control their consent profile through the Citizen portal: data sharing, emergency access, insurance access, AI processing, research participation, family linking. Changes take immediate effect. |
| **Purpose limitation** | Each portal accesses only the data relevant to its function. Role-based access control (RBAC) and object-level authorization (BOLA) prevent cross-boundary access. |
| **Data minimization** | Family health records mask National IDs of relatives. Research data is anonymized. Emergency access provides only clinically essential information. |
| **Accountability and auditability** | The Isnād chain records every access, decision, and consent change with cryptographic integrity verification. |
| **Breach detection** | Tamper-evident audit chain detects unauthorized modifications. Integrity can be verified on demand. |

### 2.3 Emergency Access and Break-Glass Protocol

SANAD permits emergency access to patient records without prior consent when clinical necessity demands it (e.g., unconscious patient). This access is:

- Immediately available (no approval delay).
- Logged permanently in the Isnād audit chain with the accessing identity, timestamp, and clinical context.
- Subject to post-hoc review by the relevant oversight authority.

This balances the duty of care with the principle of accountability — access is never blocked when lives are at risk, but it is never silent.

---

## 3. Governance Model

### 3.1 AI Accountability Framework

Every AI decision in SANAD follows a structured accountability path:

1. **Decision generation:** The clinical decision engine computes a risk score, urgency classification, contributing factors, and recommendations based on the patient's clinical record.
2. **Explainability record:** Each factor is documented with its contribution weight and confidence level, forming the "WHY" component of the audit record.
3. **Isnād recording:** The decision is hash-chained (SHA-256) to the previous record, creating a tamper-evident sequence. The record captures WHO (the triggering actor), WHAT (the decision), WHEN (timestamp), and WHY (the explainability payload).
4. **Integrity verification:** The entire audit chain can be verified in a single operation from the Ministry portal. Any alteration to any record produces a chain-integrity failure.

### 3.2 Consent Rights Architecture

Consent in SANAD is not a one-time agreement. It is a set of granular, revocable permissions enforced at the data boundary:

- **Data sharing:** General health-record sharing with authorized providers.
- **Emergency access:** Permission for break-glass retrieval (typically always on, but logged).
- **Insurance access:** Whether the insurer can view the citizen's clinical record for claims processing.
- **AI processing:** Whether AI engines may process the citizen's data for decision support.
- **Research participation:** Opt-in consent for inclusion in anonymized research datasets.
- **Family health linking:** Whether family members with reciprocal consent may view shared genetic risk assessments.

Each consent type is individually controllable, carries its legal basis, and produces an Isnād record when changed.

### 3.3 Oversight Infrastructure

SANAD provides the Ministry with:

- **National dashboard:** Real-time population health statistics, risk distribution, disease prevalence, and visit trends — derived from the same clinical data that powers individual portals.
- **AI Control Center:** Monitoring of all AI engine operations, including confidence trends, decision volumes, and drift detection.
- **Audit chain verification:** One-click verification of the integrity of the entire national Isnād chain.
- **Policy intelligence:** Disease-burden analysis, epidemic radar, and population-health insights to support evidence-based policy decisions.

---

## 4. Phased National Rollout

### Phase 1: Pilot Deployment (2–3 hospitals)

**Scope:**
- Deployment of the full SANAD platform in 2–3 pilot facilities (selection criteria: willingness, existing digital maturity, patient volume diversity).
- Integration with existing hospital information systems at pilot sites.
- PDPL compliance certification process initiated.
- Clinician training and adoption support.

**Success gates:**
- Platform operational stability in production clinical environment.
- Clinician adoption: target of active daily use by participating physicians (illustrative target: majority of physicians in pilot facilities).
- Zero critical-severity system-availability incidents during pilot period.
- Successful PDPL compliance review.
- Isnād audit chain integrity maintained throughout pilot.

### Phase 2: Regional Expansion (target region)

**Scope:**
- Expansion to additional facilities within a target region.
- Integration with regional health registries and referral networks.
- Expanded specialty module coverage in the clinical decision engine.
- Insurance portal activation with participating regional insurers.

**Success gates:**
- Cross-facility interoperability verified (patient records accessible across facilities with appropriate consent).
- Drug-interaction engine coverage expanded to regional formulary.
- Regional population-health analytics operational on Ministry dashboard.
- No PDPL compliance findings from regulatory review.

### Phase 3: National Deployment

**Scope:**
- Rollout to public and private sector facilities nationwide.
- Full integration with national health registries and MOH reporting systems.
- Isnād chain established as the national standard for AI-decision auditability in healthcare.
- Supply-chain portal activated for national drug-shortage monitoring.

**Success gates:**
- National population-health intelligence operational.
- Cross-sector consent enforcement verified (citizen consent changes propagate across all participating institutions).
- Ministry AI Control Center operational for national AI governance.
- Isnād audit integrity verifiable at national scale.

---

## 5. Risk and Mitigation

| Risk | Likelihood | Impact | Mitigation |
|---|---|---|---|
| **Clinician resistance to AI-assisted workflows** | Medium | High | Phased introduction with training; explainable AI design reduces "black box" anxiety; physician retains final decision authority. |
| **Integration complexity with existing HIS** | Medium | Medium | Standards-based API architecture; pilot phase identifies integration patterns before scale. |
| **Data quality variance across facilities** | Medium | Medium | Input validation at data boundary; AI engines designed for graceful degradation on incomplete data. |
| **Regulatory framework evolution** | Low | Medium | Architecture designed for extensibility; consent model and audit chain accommodate additional regulatory requirements. |
| **Cybersecurity threats** | Low | High | Role-based access control, object-level authorization, tamper-evident audit, encryption at rest and in transit. |
| **Scaling performance under national load** | Low | High | Architecture validated at pilot scale; horizontal scaling path designed; performance benchmarks established before each phase gate. |

---

## 6. Success Criteria

### Clinical Impact (illustrative pilot targets)
- Reduction in missed drug interactions at the point of care.
- Reduction in time-to-clinical-decision for complex patients.
- Measurable clinician engagement with AI-generated recommendations.

### Governance Impact
- Full PDPL compliance verified by independent review.
- Isnād audit chain integrity maintained across all deployment phases.
- Citizen consent-change propagation verified within target SLA.

### Operational Impact
- Platform availability meeting defined SLA (target: high availability).
- AI decision-engine response time within defined performance envelope.
- Successful integration with target number of hospital information systems.

*Note: All targets listed above are illustrative pilot targets and will be refined through baseline measurement during Phase 1. No measured results are claimed prior to deployment.*

---

## 7. Governance and Oversight Asks

Sanad Technologies requests the following from the Ministry to enable national deployment:

1. **Pilot-site designation:** Identification and authorization of 2–3 pilot facilities for Phase 1 deployment, with MOH endorsement of the pilot program.

2. **Regulatory engagement:** Formal engagement channel with PDPL regulatory authority for compliance certification and ongoing regulatory alignment.

3. **Data-governance framework alignment:** Collaborative development of AI-decision auditability standards, with SANAD's Isnād architecture as a proposed reference implementation.

4. **Integration authorization:** Authorization to integrate with national health registries and MOH reporting systems under defined data-sharing agreements.

5. **Oversight committee:** Establishment of a joint oversight committee (MOH + Sanad Technologies) for pilot governance, with defined reporting cadence and escalation procedures.

6. **National AI governance contribution:** Opportunity for SANAD's Isnād framework to contribute to national standards for AI accountability in the health sector, in coordination with SDAIA and relevant regulatory bodies.

---

**Sanad Technologies**
SANAD Health — Behind Every Decision
لكل قرارٍ سند
